← Back to search

INCYTE CORPORATION

INCY · NASDAQ

Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)

Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics.

ESG Scores

Overall ESG
7.1
Environmental
4.7
Social
4.1
Governance
7.1

Gender Diversity

Female Directors0.3333%
Female Executives0.15555555555555556%
Women in Workforce0.51%
CEO GenderMale

Market Data

Price$101.24+3.26 (+3.33%)
Market Cap$20.14B
P/E Ratio14.07
EPS$—
52W High$112.29
52W Low$66.30
Beta0.80